BASF SE - BAS.DE

BAS.DE Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
BAS.DE	2.8	5.6	10.0	1.8	7.5	3.0	-30.2	-24.4	-39.5	773.6
S&P 500	-0.3	1.4	1.1	5.0	11.8	24.7	40.3	88.1	196.6	34448.4

Compare BAS.DE with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	BAS.DE
name	BASF SE
price	47
changes percentage	2.8334
change	1.295
day low	45.945
day high	47.445
year high	54.93
year low	40.175
market cap	42011185000
price avg 50	43.2049
price avg 200	45.120174
exchange	XETRA
volume	4346734
avg volume	2161968
open	45.995
previous close	45.705
eps	0.55
pe	85.45
earnings announcement	2025-02-28T06:00:00.000+0000
shares outstanding	893855000
timestamp	2025-01-24 16:38:13

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 43.3%

Overall Quarterly Financial Health: 50.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	68902000000	87327000000	-21.10
gross profit	16702000000	21067000000	-20.72
gross profit ratio	0.24	0.24	0.48
research and development expenses	2130000000	2298000000	-7.31
operating expenses	14462000000	14100000000	2.57
interest income	322000000	373000000	-13.67
interest expense	971000000	721000000	34.67
ebitda	7332000000	10216000000	-28.23
ebitdaratio	0.11	0.08	39.30
operating income	2240000000	2471000000	-9.35
operating income ratio	0.03	0.03	14.89
net income	225000000	-391000000	157.54
net income ratio	0.0	-0.0	172.93
eps	0.25	-0.43	158.14

Overall Score of Annual Income Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 68,902 million in 2023 from 87,327 million in 2022 representing a change of -21.1%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 16,702 million in 2023 from 21,067 million in 2022 representing a change of -20.72%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 2,130 million in 2023 from 2,298 million in 2022 representing a change of -7.31%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 14,462 million in 2023 from 14,100 million in 2022 representing a change of 2.57%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 2,240 million in 2023 from 2,471 million in 2022 representing a change of -9.35%. The decrease in operating income indicates worse operational performance and decreased profitability.

• 📈 Positive Indicators

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 7,332 million in 2023 from 10,216 million in 2022 representing a change of -28.23%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to 225 million in 2023 from -391 million in 2022 representing a change of 157.54%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.25 in 2023 from 0.25 in 2022 representing a change of 158.14%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	15739000000	16111000000	-2.31
gross profit	3827000000	4191000000	-8.69
gross profit ratio	0.24	0.26	-6.53
research and development expenses	506000000	524000000	-3.44
operating expenses	3025000000	3151000000	-4.00
interest income	80000000	91000000	-12.09
interest expense	236000000	239000000	-1.26
ebitda	1345000000	1649000000	-18.44
ebitdaratio	0.09	0.13	-34.03
operating income	802000000	1040000000	-22.88
operating income ratio	0.05	0.06	-21.06
net income	287000000	430000000	-33.26
net income ratio	0.02	0.03	-31.68
eps	0.32	0.48	-33.33

Overall Score of Quarterly Income Statement

0.25 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 15,739 million in 2024Q3 from 16,111 million in 2024Q2 representing a change of -2.31%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 3,827 million in 2024Q3 from 4,191 million in 2024Q2 representing a change of -8.69%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 506 million in 2024Q3 from 524 million in 2024Q2 representing a change of -3.44%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 1,345 million in 2024Q3 from 1,649 million in 2024Q2 representing a change of -18.44%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Net Income: Net income decreased to 287 million in 2024Q3 from 430 million in 2024Q2 representing a change of -33.26%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.32 in 2024Q3 from 0.32 in 2024Q2 representing a change of -33.33%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Operating Expenses: Operating Expenses decreased to 3,025 million in 2024Q3 from 3,151 million in 2024Q2 representing a change of -4.0%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Operating Income: Operating income increased to 802 million in 2024Q3 from 1,040 million in 2024Q2 representing a change of -22.88%. The increase in operating income indicates better operational performance and increased profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	79927000000	84472000000	-5.38
total liabilities	43282000000	43549000000	-0.61
total equity	36645000000	37947000000	-3.43
cash and cash equivalents	2624000000	2516000000	4.29
short term investments	53000000	232000000	-77.16
long term investments	8275000000	8121000000	1.90
total current assets	31472000000	37422000000	-15.90
total non current assets	48455000000	39302000000	23.29
total current liabilities	15871000000	20440000000	-22.35
total non current liabilities	27411000000	15192000000	80.43
common stock	1142000000	1144000000	-0.17
retained earnings	31451000000	35453000000	-11.29
total debt	21347000000	20949000000	1.90

Overall Score of Annual Balance Sheet

0.3 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 79,927 million in 2023 from 84,472 million in 2022 representing a change of -5.38%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 36,645 million in 2023 from 37,947 million in 2022 representing a change of -3.43%. This indicates a decrease in shareholders' equity.

  Short Term Investments: Short Term Investments decreased to 53 million in 2023 from 232 million in 2022 representing a change of -77.16%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 31,472 million in 2023 from 37,422 million in 2022 representing a change of -15.9%. This indicates a worsen liquidity position.

  Common Stock: Common Stock decreased to 1,142 in 2023 from 1,144 in 2022 representing a change of -0.17%. This indicates a decrease in ownership interest.

  Retained Earnings: Retained Earnings decreased to 31,451 million in 2023 from 35,453 million in 2022 representing a change of -11.29%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 21,347 million in 2023 from 20,949 million in 2022 representing a change of 1.9%. This indicates an increase in overall debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 43,282 million in 2023 from 43,549 million in 2022 representing a change of -0.61%. This indicates a decrease in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 2,624 million in 2023 from 2,516 million in 2022 representing a change of 4.29%. This indicates an increase in available liquid assets.

  Total Current Liabilities: Total Current Liabilities decreased to 15,871 million in 2023 from 20,440 million in 2022 representing a change of -22.35%. This indicates a lower short-term debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	79359000000	82447000000	-3.75
total liabilities	43314000000	45726000000	-5.27
total equity	36045000000	36721000000	-1.84
cash and cash equivalents	2572000000	2229000000	15.39
short term investments	33000000	59000000	-44.07
long term investments	7878000000	8553000000	-7.89
total current assets	31718000000	33753000000	-6.03
total non current assets	47641000000	48694000000	-2.16
total current liabilities	16988000000	19917000000	-14.71
total non current liabilities	26326000000	25809000000	2.00
common stock	1142000000	1142000000	0.00
retained earnings	31654000000	31277000000	1.21
total debt	22309000000	23729000000	-5.98

Overall Score of Quarterly Balance Sheet

0.56 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 79,359 million in 2024Q3 from 82,447 million in 2024Q2 representing a change of -3.75%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 36,045 million in 2024Q3 from 36,721 million in 2024Q2 representing a change of -1.84%. This indicates a decrease in shareholders' equity.

  Short Term Investments: Short Term Investments decreased to 33 million in 2024Q3 from 59 million in 2024Q2 representing a change of -44.07%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 31,718 million in 2024Q3 from 33,753 million in 2024Q2 representing a change of -6.03%. This indicates a worsen liquidity position.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 43,314 million in 2024Q3 from 45,726 million in 2024Q2 representing a change of -5.27%. This indicates a decrease in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 2,572 million in 2024Q3 from 2,229 million in 2024Q2 representing a change of 15.39%. This indicates an increase in available liquid assets.

  Total Current Liabilities: Total Current Liabilities decreased to 16,988 million in 2024Q3 from 19,917 million in 2024Q2 representing a change of -14.71%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 31,654 million in 2024Q3 from 31,277 million in 2024Q2 representing a change of 1.21%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 22,309 million in 2024Q3 from 23,729 million in 2024Q2 representing a change of -5.98%. This indicates a reduction in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	108000000	-108000000	200.00
operating cash flow	8111000000	7709000000	5.21
free cash flow	2716000000	3334000000	-18.54
capital expenditure	-5395000000	-4375000000	-23.31
depreciation and amortization	3921000000	4200000000	-6.64
deferred income tax	0	0	NaN
stock based compensation	26000000	20000000	30.00
accounts payables	-1544000000	-786000000	-96.44
inventory	1896000000	-1991000000	195.23
acquisitions net	1503000000	678000000	121.68
investments in property plant and equipment	-5395000000	-4375000000	-23.31
net cash used for investing activites	-4991000000	-3778000000	-32.11
debt repayment	259000000	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-70000000	-1331000000	94.74
dividends paid	-3034000000	-3072000000	1.24
net cash used provided by financing activities	-2905000000	-4013000000	27.61
cash at end of period	2624000000	2516000000	4.29
accounts receivables	1443000000	2145000000	-32.73
cash at beginning of period	2516000000	2624000000	-4.12

Overall Score of Annual Cashflow Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 108 million in 2023 from -108 million in 2022 representing a change of 200.0%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 8,111 million in 2023 from 7,709 million in 2022 representing a change of 5.21%. This indicates that the company generated more cash from its core business operations.

  Capital Expenditure: Capital Expenditure decreased to -5,395 million in 2023 from -4,375 million in 2022 representing a change of -23.31%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to 1,443 million in 2023 from 2,145 million in 2022 representing a change of -32.73%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -3,034 million in 2023 from -3,072 million in 2022 representing a change of 1.24%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Free Cash Flow: Free Cash Flow decreased to 2,716 million in 2023 from 3,334 million in 2022 representing a change of -18.54%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation increased to 26 million in 2023 from 20 million in 2022 representing a change of 30.0%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 1,544 million in 2023 from 786 million in 2022 representing a change of -96.44%. This indicates that the company has increased its outstanding obligations to its suppliers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	2052000000	1950000000	5.23
free cash flow	568000000	470000000	20.85
capital expenditure	-1484000000	-1480000000	-0.27
depreciation and amortization	962000000	1047000000	-8.12
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	1180000000	1028000000	14.79
accounts payables	-841000000	86000000	-1077.91
inventory	149000000	-403000000	136.97
acquisitions net	5000000	-151000000	103.31
investments in property plant and equipment	-1484000000	-1480000000	-0.27
net cash used for investing activites	-289000000	-2148000000	86.55
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-20000000	0	NaN
dividends paid	-79000000	-3088000000	97.44
net cash used provided by financing activities	-1392000000	-355000000	-292.11
net change in cash	343000000	-557000000	161.58
cash at end of period	2572000000	2229000000	15.39
cash at beginning of period	2229000000	2786000000	-19.99

Overall Score of Quarterly Cashflow Statement

0.71 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 343 million in 2024Q3 from -557 million in 2024Q2 representing a change of 161.58%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 2,052 million in 2024Q3 from 1,950 million in 2024Q2 representing a change of 5.23%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 568 million in 2024Q3 from 470 million in 2024Q2 representing a change of 20.85%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -1,484 million in 2024Q3 from -1,480 million in 2024Q2 representing a change of -0.27%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Dividends Paid: Dividends Paid increased to -79 million in 2024Q3 from -3,088 million in 2024Q2 representing a change of 97.44%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Accounts Payables: The absolute value of Accounts Payables increased to 841 million in 2024Q3 from 86 million in 2024Q2 representing a change of -1077.91%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 1,180 in 2024Q3 from 1,028 million in 2024Q2 representing a change of 14.79%. This suggests that the company is less capable of collecting payments from its customers.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	77.19	96.84	-20.29
net income per share	0.25	-0.43	158.13
operating cash flow per share	9.09	8.55	6.29
free cash flow per share	3.04	3.7	-17.70
cash per share	3.0	3.05	-1.59
book value per share	41.05	45.38	-9.54
tangible book value per share	27.37	30.66	-10.75
shareholders equity per share	39.52	40.58	-2.62
interest debt per share	25.0	24.03	4.04
market cap	43543027980	41832368060	4.09
enterprise value	62266027980	60265368060	3.32
pe ratio	193.52	-106.99	280.88
price to sales ratio	0.63	0.48	31.92
pocfratio	5.37	5.43	-1.07
pfcf ratio	16.03	12.55	27.77
pb ratio	1.23	1.14	7.98
ptb ratio	1.23	1.14	7.98
ev to sales	0.9	0.69	30.95
enterprise value over ebitda	8.49	5.9	43.96
ev to operating cash flow	7.68	7.82	-1.80
ev to free cash flow	22.93	18.08	26.83
earnings yield	0.01	-0.01	155.28
free cash flow yield	0.06	0.08	-21.74
debt to equity	0.61	0.57	5.71
debt to assets	0.27	0.25	7.69
net debt to ebitda	2.55	1.8	41.53
current ratio	1.98	1.83	8.31
interest coverage	2.31	3.43	-32.69
income quality	36.05	-12.3	393.20
dividend yield	0.07	0.07	-5.12
payout ratio	13.48	-7.86	271.63
sales general and administrative to revenue	0.02	0.02	25.57
research and ddevelopement to revenue	0.03	0.03	17.48
intangibles to total assets	0.15	0.16	-2.73
capex to operating cash flow	0.67	0.57	17.20
capex to revenue	0.08	0.05	56.29
capex to depreciation	1.38	1.04	32.09
stock based compensation to revenue	0.0	0.0	64.76
graham number	14.97	19.9	-24.76
roic	0.01	-0.01	166.91
return on tangible assets	0.0	-0.01	160.51
graham net net	-27.33	-24.23	-12.82
working capital	15601000000	16982000000	-8.13
tangible asset value	24429000000	27650000000	-11.65
net current asset value	-11810000000	-6127000000	-92.75
invested capital	51897000000	53222000000	-2.49
average receivables	13503000000	14464500000	-6.65
average payables	7587500000	8130000000	-6.67
average inventory	14908500000	14846000000	0.42
days sales outstanding	65.48	61.22	6.96
days payables outstanding	47.14	46.46	1.45
days of inventory on hand	97.03	87.81	10.49
receivables turnover	5.57	5.96	-6.51
payables turnover	7.74	7.86	-1.43
inventory turnover	3.76	4.16	-9.50
roe	0.01	-0.01	159.70
capex per share	6.04	4.85	24.57

• Negative

  ROE: Return on Equity (ROE) increased to 0.01 on 2023-12-31 from -0.01 on 2022-12-31, representing a change of 159.70%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 193.52 on 2023-12-31 from -106.99 on 2022-12-31, representing a change of 280.88%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.98 on 2023-12-31 from 1.83 on 2022-12-31, representing a change of 8.31%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.61 on 2023-12-31 from 0.57 on 2022-12-31, representing a change of 5.71%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
BAS.DE
calendar year	2024	2024	NaN
revenue per share	17.63	18.05	-2.31
net income per share	0.32	0.48	-33.26
operating cash flow per share	2.3	2.18	5.23
free cash flow per share	0.64	0.53	20.85
cash per share	2.92	2.56	13.85
book value per share	40.39	41.14	-1.84
tangible book value per share	27.27	27.61	-1.25
shareholders equity per share	38.92	39.59	-1.70
interest debt per share	25.26	26.85	-5.94
market cap	42448346320	39619058859.96	7.14
enterprise value	62185346320	61119058859.96	1.74
pe ratio	36.98	23.03	60.53
price to sales ratio	2.7	2.46	9.67
pocfratio	20.69	20.32	1.82
pfcf ratio	74.73	84.3	-11.34
pb ratio	1.22	1.12	8.99
ptb ratio	1.22	1.12	8.99
ev to sales	3.95	3.79	4.15
enterprise value over ebitda	46.23	37.06	24.74
ev to operating cash flow	30.3	31.34	-3.31
ev to free cash flow	109.48	130.04	-15.81
earnings yield	0.01	0.01	-37.70
free cash flow yield	0.01	0.01	12.80
debt to equity	0.64	0.67	-4.36
debt to assets	0.28	0.29	-2.33
net debt to ebitda	14.67	13.04	12.55
current ratio	1.87	1.69	10.17
interest coverage	3.4	4.35	-21.90
income quality	7.15	4.53	57.66
dividend yield	0.0	0.08	-97.61
payout ratio	0.28	7.18	-96.17
sales general and administrative to revenue	0.02	0.02	-5.03
research and ddevelopement to revenue	0.03	0.03	-1.15
intangibles to total assets	0.15	0.15	0.72
capex to operating cash flow	0.72	0.76	-4.71
capex to revenue	0.09	0.09	2.64
capex to depreciation	1.54	1.41	9.13
stock based compensation to revenue	0	0	NaN
graham number	16.78	20.72	-19.00
roic	0.01	0.02	-61.10
return on tangible assets	0.0	0.01	-30.57
graham net net	-28.07	-29.71	5.50
working capital	14730000000	13836000000	6.46
tangible asset value	24338000000	24646000000	-1.25
net current asset value	-11596000000	-11973000000	3.15
invested capital	52114000000	51270000000	1.65
average receivables	12088000000	13033000000	-7.25
average payables	6315000000	6731500000	-6.19
average inventory	14445500000	14451000000	-0.04
days sales outstanding	64.99	71.57	-9.19
days payables outstanding	44.23	51.16	-13.55
days of inventory on hand	107.72	110.48	-2.50
receivables turnover	1.38	1.26	10.12
payables turnover	2.03	1.76	15.67
inventory turnover	0.84	0.81	2.56
roe	0.01	0.01	-32.10
capex per share	1.66	1.66	0.27

• Negative

  ROE: Return on Equity (ROE) decreased to 0.01 on 2024-09-30 Q3 from 0.01 on 2024-06-30 Q2, representing a change of -32.10%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 36.98 on 2024-09-30 Q3 from 23.03 on 2024-06-30 Q2, representing a change of 60.53%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.87 on 2024-09-30 Q3 from 1.69 on 2024-06-30 Q2, representing a change of 10.17%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.64 on 2024-09-30 Q3 from 0.67 on 2024-06-30 Q2, representing a change of -4.36%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 54.48 which is higher than current price 47, indicates the company may be undervalued.